Oxidative Medicine and Cellular Longevity / 2018 / Article / Tab 2

Research Article

Flavoprotein Fluorescence Correlation with Visual Acuity Response in Patients Receiving Anti-VEGF Injection for Diabetic Macular Edema

Table 2

Measurements pre- and postinjection. For each subject, all preinjection measurements were taken on the day of injection, and postinjection measurements were taken at a follow-up visit days later. BCVA = best corrected visual acuity; FPF = flavoprotein fluorescence; OCT = optical coherence tomography; CMT = central macular thickness; gsu = grayscale units.

Subject IDPreinjection BCVAPostinjection BCVAPreinjection OCT CMT (μm)Postinjection OCT CMT (μm)Preinjection FPF (gsu)Postinjection FPF (gsu)Postinjection
follow-up visit
(days)
Injection position in current series

00120/5020/30371.8NA43727272
00620/15020/100582.2518.8181156141
00820/10020/70574541.2589506283
00720/6020/50392.8334.4574505561
01120/15020/400594.4NA490569561
00320/8020/100540545.84654771293
02820/2020/25319296423441271
02620/2020/20344.6329.4312303393

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.